SCHEDULE: BlackRock Amends Passive Stake in PROKIDNEY CORP to 1.4%

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a passive beneficial ownership of 1.4% in PROKIDNEY CORP's Class A Stock.

Summary

• BlackRock, Inc. reported beneficial ownership of 1,764,602 shares of PROKIDNEY CORP's Class A Stock.
• This represents 1.4% of the Class A Stock outstanding.
• BlackRock holds sole voting power over 1,756,859 shares and sole dispositive power over 1,764,602 shares.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating a passive investment.
• The filing was made by BlackRock, Inc. as a parent holding company, with several BlackRock subsidiaries identified as entities that may beneficially own shares.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing disclosing passive ownership, which is neutral in sentiment. It does not contain positive or negative performance indicators or strategic announcements.

Future Outlook

NA

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.

Industry Context

Schedule 13G filings are standard disclosures by institutional investors like BlackRock, indicating passive ownership stakes below 5% (or above 5% but passive) in publicly traded companies. This filing reflects BlackRock's ongoing portfolio management activities and its position as a significant, but non-controlling, shareholder in PROKIDNEY CORP, a common practice for large asset managers.

Key Dates

Keywords

BlackRock, PROKIDNEY CORP, Schedule 13G, Beneficial Ownership, Class A Stock, Institutional Investor, SEC Filing, Passive Investment